>> Continued From the Previous Page <<
“The person developed symptoms over the weekend and tested positive late Sunday,” Dr. Satish Pillai, the incident manager for the agency’s Ebola response, told reporters on a media call.
He also detailed the coordinated international response already underway, emphasizing cooperation between U.S. agencies and foreign partners.
“CDC has been working hand in hand with the Department of State to move the American for treatment and care to Germany and other high-risk contacts to Germany for monitoring,” Pillai added Monday in a media briefing.
The directive was issued under Title 42, a public health authority that allows federal officials to restrict entry into the country during communicable disease threats. The tool gained widespread attention during earlier border and pandemic-era policy disputes, and its renewed use is likely to draw scrutiny once again.
The measure includes several exemptions. U.S. citizens, U.S. nationals, lawful permanent residents, members of the U.S. military, and government personnel stationed overseas—as well as their immediate family members—are not subject to the restriction. Additional exceptions may also be granted on a case-by-case basis by the Department of Homeland Security.
Public health experts acknowledge that travel restrictions can play a role in containment strategies, though they caution that such measures are not a standalone solution. Dr. Jeanne Marrazzo of the Infectious Diseases Society of America noted that coordination across borders is critical in limiting spread.
However, she also warned that targeted policies alone have limits, stating that policies that “single out non-US citizens won’t prevent viruses from crossing our borders.”
The action follows the World Health Organization’s declaration that the outbreak constitutes a public health emergency, underscoring the seriousness of the situation and the potential for international spread. World Health Organization
Early estimates from health authorities suggest the outbreak may have already caused approximately 80 deaths in recent weeks. Officials have also confirmed additional Ebola cases in neighboring Uganda, raising concerns that the virus may be expanding beyond its initial containment zones in the Democratic Republic of the Congo. Uganda Democratic Republic of the Congo South Sudan
On the ground, medical teams have been deployed rapidly to affected areas in eastern regions, where transmission appears to be accelerating. The speed at which new cases have emerged, combined with delays in detection, has raised alarms among epidemiologists monitoring the situation closely.
According to the Congo Health Cluster, reported figures currently include 105 suspected deaths and 393 suspected cases, though officials caution that these numbers may change as investigations continue.
A key factor driving concern is the nature of the virus itself. The CDC noted that the strain involved—Bundibugyo Ebola virus—can incubate for as long as 21 days, meaning infected individuals may travel internationally before showing any visible symptoms.
“The risk of Bundibugyo (Ebola) virus disease introduction into the United States is heightened by the virus’ incubation period, which can extend up to 21 days, allowing infected individuals to travel internationally while asymptomatic and therefore unlikely to be detected through routine symptom-based screening measures,” the agency said.
Despite the heightened precautions, officials emphasized that the overall risk to the American public remains low at this time. “At this time, CDC assesses the immediate risk to the general US public as low, but we will continue to evaluate the evolving situation and may adjust public health measures as additional information becomes available,” the agency added.
Meanwhile, U.S. health authorities are also working on longer-term medical countermeasures. The Biomedical Advanced Research and Development Authority (BARDA) is currently involved in developing a monoclonal antibody therapy that could be used to treat infections tied to this strain of Ebola.
Officials also stressed that the United States has robust diagnostic capabilities through its public health laboratory network, allowing for rapid detection and response if cases appear domestically. Dr. Pillai reiterated that while vigilance is essential, the current assessment still places the risk to the U.S. at a low level, according to reporting from Reuters.
